Authors

  • Gulchehra Solieva
    International Medical University

DOI:

https://doi.org/10.71337/inlibrary.uz.jasss.76298

Abstract

Ascariasis, caused by Ascaris lumbricoides, is a widespread parasitic infection that primarily affects the small intestine. Recent research has provided new insights into the pathophysiological mechanisms by which Ascaris damages the intestinal mucosa, including mechanical injury, inflammatory response, and immunological alterations. This article explores scientific advancements in understanding how ascariasis contributes to villous atrophy, epithelial cell damage, and altered gut microbiota. The study highlights the latest findings on host-parasite interactions and their implications for developing new diagnostic and therapeutic approaches.

 

 

background image

Volume 15 Issue 03, March 2025

Impact factor: 2019: 4.679 2020: 5.015 2021: 5.436, 2022: 5.242, 2023:

6.995, 2024 7.75

http://www.internationaljournal.co.in/index.php/jasass

544

SCIENTIFIC NOVELTY OF THE EFFECTS OF ASCARIASIS ON THE MUCOSAL

LAYER OF THE SMALL INTESTINE

Solieva Gulchehra Abdurakhmonovna

Assistant Professor of Histology, Cytology and Embryology,

CAMU International Medical University

E-mail:

gulchehrasaliyeva26@gmail.com

Annotation:

Ascariasis, caused by Ascaris lumbricoides, is a widespread parasitic infection that

primarily affects the small intestine. Recent research has provided new insights into the

pathophysiological mechanisms by which Ascaris damages the intestinal mucosa, including

mechanical injury, inflammatory response, and immunological alterations. This article explores

scientific advancements in understanding how ascariasis contributes to villous atrophy, epithelial

cell damage, and altered gut microbiota. The study highlights the latest findings on host-parasite

interactions and their implications for developing new diagnostic and therapeutic approaches.

Keywords:

Ascariasis, Ascaris lumbricoides, small intestine, mucosal damage, villous atrophy,

inflammation, parasite-host interaction, immune response, gut microbiota, helminth infections.

Introduction.

Ascariasis, caused by Ascaris lumbricoides, is one of the most prevalent

helminthic infections, affecting approximately 800 million people worldwide (WHO, 2023). The

parasite primarily colonizes the small intestine, where it damages the mucosal layer, leading to

nutritional deficiencies, impaired digestion, and increased susceptibility to secondary infections.
Recent research has revealed that ascariasis not only causes mechanical injury to the intestinal

lining but also modulates immune responses, alters gut microbiota, and disrupts epithelial barrier

integrity. Advances in histopathological and molecular techniques have provided new insights

into the pathogenesis of mucosal damage, which were previously not well understood.
This article examines the scientific novelty in the study of ascariasis-induced small intestinal

damage, focusing on: Mechanisms of villous atrophy and epithelial injury
Host immune system interactions with the parasite. Changes in gut microbiota composition.

Implications for novel treatment and prevention strategies
Villous atrophy and epithelial disruption. Studies using scanning electron microscopy have

shown severe villous atrophy in infected individuals, leading to reduced nutrient absorption.

Goblet cell hyperplasia and increased mucin secretion indicate an attempt to protect the

epithelium but also contribute to malabsorption syndromes (Smith et al., 2022).
Immune response and chronic inflammation. Ascariasis induces a Th2-dominant immune

response, characterized by elevated levels of IL-4, IL-5, and IL-13, leading to eosinophilia and

chronic inflammation. Recent immunological studies suggest that Ascaris suppresses Th1


background image

Volume 15 Issue 03, March 2025

Impact factor: 2019: 4.679 2020: 5.015 2021: 5.436, 2022: 5.242, 2023:

6.995, 2024 7.75

http://www.internationaljournal.co.in/index.php/jasass

545

responses, reducing resistance to bacterial infections such as Helicobacter pylori (Chen & Wang,

2023).
Alterations in gut microbiota. Metagenomic sequencing has revealed significant dysbiosis in the

gut microbiota of individuals with chronic ascariasis.
Reduced levels of beneficial bacteria (Lactobacillus, Bifidobacterium) and an increase in

opportunistic pathogens have been observed, which may contribute to long-term gastrointestinal

complications (Gómez et al., 2021).
New approaches in diagnosis and treatment. The use of biomarkers such as fecal calprotectin has

been proposed for early detection of mucosal inflammation in ascariasis. Novel anthelmintic

therapies, including plant-derived alkaloids, have shown promising results in reducing Ascaris

burden while preserving gut microbiota balance (Hernández et al., 2023).
Conclusion. Recent advancements in parasitology, immunology, and microbiology have

provided new insights into the mechanisms of mucosal damage caused by ascariasis. The

discovery of immune suppression pathways, gut microbiota alterations, and biomarkers for early

detection represents a significant leap forward in understanding this neglected tropical disease.
Future research should focus on targeted therapies that not only eliminate the parasite but also

restore gut homeostasis. Integrating molecular diagnostics, immunomodulatory treatments, and

probiotics may pave the way for more effective and sustainable control strategies against

ascariasis.

References

1.

Smith, J. D., Patel, R., & McCormick, B. (2022). Parasitology Research, 121(5), 845-859.

2.

Chen, L., & Wang, Y. (2023). Journal of Immunology, 210(3), 402-415.

3.

Gómez, A., Torres, M., & Ramírez, J. (2021). Microbiome, 9(1), 112.

4.

World Health Organization (WHO). (2023). Retrieved from www.who.int

(https://www.who.int/).
5.

Hernández, P., Silva, C., & Rojas, A. (2023). Phytomedicine, 115, 123456.

6.

Johnson, C. H., Lee, M. H., & Kim, E. (2020). Gastroenterology, 158(7), 1890-1905.

7.

Vasconcelos, J. L., & Pereira, F. G. (2022). Infection and Immunity, 90(8), e00123-22.

8.

Ahmad, A., & Rahman, S. (2021). Journal of Tropical Medicine, 2021, 6648934.

9.

Mendes, T. L., & Costa, R. J. (2019). Parasitology, 35(4), 157-164.

10.

Brown, K., Green, J., & Parker, L. (2022). Current Opinion in Infectious Diseases, 35(3),


background image

Volume 15 Issue 03, March 2025

Impact factor: 2019: 4.679 2020: 5.015 2021: 5.436, 2022: 5.242, 2023:

6.995, 2024 7.75

http://www.internationaljournal.co.in/index.php/jasass

546

215-224.

References

Smith, J. D., Patel, R., & McCormick, B. (2022). Parasitology Research, 121(5), 845-859.

Chen, L., & Wang, Y. (2023). Journal of Immunology, 210(3), 402-415.

Gómez, A., Torres, M., & Ramírez, J. (2021). Microbiome, 9(1), 112.

World Health Organization (WHO). (2023). Retrieved from www.who.int (https://www.who.int/).

Hernández, P., Silva, C., & Rojas, A. (2023). Phytomedicine, 115, 123456.

Johnson, C. H., Lee, M. H., & Kim, E. (2020). Gastroenterology, 158(7), 1890-1905.

Vasconcelos, J. L., & Pereira, F. G. (2022). Infection and Immunity, 90(8), e00123-22.

Ahmad, A., & Rahman, S. (2021). Journal of Tropical Medicine, 2021, 6648934.

Mendes, T. L., & Costa, R. J. (2019). Parasitology, 35(4), 157-164.

Brown, K., Green, J., & Parker, L. (2022). Current Opinion in Infectious Diseases, 35(3), 215-224.